You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gallbladder carcinoma

Showing 1 - 25 of 8,479
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gallbladder Carcinoma Trial in Shanghai (gemcitabine and oxaliplatin., Afatinib)

Recruiting
  • Gallbladder Carcinoma
  • Shanghai, Shanghai, China
  • +1 more
Dec 21, 2022

Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical

Recruiting
  • Incidental Gallbladder Carcinoma
  • Biliary Tract Cancer
  • Frankfurt, Germany
    Krankenhaus Nordwest gGmbH
Sep 7, 2022

Comprehensive Genomic Profiling Combined With Real Life Data of

Active, not recruiting
  • Gallbladder Carcinoma
    • Frankfurt am Main, Germany
      Institut für Klinische Krebsforschung IKF GmbH
    Jan 31, 2022

    Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

    Active, not recruiting
    • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
    • +27 more
    • Los Angeles, California
    • +2 more
    Aug 5, 2022

    Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

    Not yet recruiting
    • Esophageal Cancer
    • +9 more
    • (no location specified)
    Feb 2, 2023

    Incidental Gallbladder Carcinoma-Permanent Platform Including

    Recruiting
    • Biliary Tract Cancer
    • Neoadjuvant, Adjuvant and 1st Line
      • Frankfurt, Germany
        Krankenhaus Nordwest GmbH
      Aug 3, 2022

      Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

      Active, not recruiting
      Has Results
      • Advanced Bile Duct Carcinoma
      • +17 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 5, 2023

      Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)

      Recruiting
      • Gallbladder Cancer
      • Everolimus 10 mg
      • Standard of care
      • Varanasi, UP, India
        Banaras Hindu University
      Apr 18, 2023

      Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Stage III Gallbladder Cancer AJCC v7 Trial in Houston

      Completed
      • Cholangiocarcinoma
      • +11 more
      • Laboratory Biomarker Analysis
      • Ramucirumab
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 7, 2022

      Therapeutic Assistance and Decision-making Algorithms in

      Not yet recruiting
      • Hepatocellular Carcinoma
      • +5 more
      • ADBoard
      • Berlin, Germany
        Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
      Jan 12, 2023

      Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

      Active, not recruiting
      • Cholangiocarcinoma
      • +3 more
      • Durvalumab
      • +3 more
      • Hannover, Germany
        Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
      Oct 14, 2021

      Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

      Active, not recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +15 more
      • Los Angeles, California
      • +1 more
      Aug 5, 2022

      Bile Duct Carcinoma, Gallbladder Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in Houston (Endoscopic Retrograde

      Recruiting
      • Bile Duct Carcinoma
      • +2 more
      • Endoscopic Retrograde Cholangiopancreatography
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 10, 2022

      Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

      Not yet recruiting
      • Carcinoma
      • +7 more
      • (no location specified)
      Nov 12, 2023

      Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7

      Completed
      Has Results
      • Stage III Intrahepatic Cholangiocarcinoma AJCC v7
      • +8 more
      • Scottsdale, Arizona
      • +2 more
      Jan 5, 2022

      Completion Radical Cholecystectomy Determine Survival in

      Completed
      • Gall Bladder Carcinoma
      • Survival
      • Curative surgery
      • (no location specified)
      Nov 5, 2021

      Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

      Suspended
      • Distal Bile Duct Adenocarcinoma
      • +7 more
      • Duarte, California
        City of Hope Medical Center
      Dec 8, 2022

      Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

      Not yet recruiting
      • Recurrent Biliary Tract Carcinoma
      • +13 more
      • (no location specified)
      Nov 8, 2022

      UCAD for Diagnosing Benign or Malignant Biliary Obstruction and

      Recruiting
      • Biliary Tract Neoplasms
      • +3 more
      • The level of CIN
      • Shanghai, Shanghai, China
        Xinhua Hospital
      Jan 12, 2023

      Hepatic Carcinoma Trial in Guangzhou (NanoKnife)

      Completed
      • Hepatic Carcinoma
      • NanoKnife
      • Guangzhou, Guangdong, China
        中国
      Sep 1, 2021

      Dietary Factors and Risk of Gallbladder Carcinoma in China

      Unknown status
      • Dietary Habits
        • Shanghai, Shanghai, China
          Xinhua Hospital
        Jan 27, 2021

        Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial

        Recruiting
        • Metastatic Distal Bile Duct Adenocarcinoma
        • +9 more
        • Atezolizumab
        • +6 more
        • Phoenix, Arizona
        • +28 more
        Dec 31, 2022

        Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

        Recruiting
        • Ovarian Neoplasms
        • +9 more
        • Aurora, Colorado
        • +6 more
        Aug 15, 2022

        Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

        Active, not recruiting
        • Breast Cancer
        • +11 more
        • radionuclide imaging
        • +4 more
        • Duarte, California
          City of Hope Medical Center
        Oct 20, 2022

        Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

        Recruiting
        • Biliary Tract Neoplasms
        • +3 more
        • Shanghai, China
          Huashan hospital
        Aug 16, 2022